120 related articles for article (PubMed ID: 21871872)
1. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide.
Taghibiglou C; Lu J; Mackenzie IR; Wang YT; Cashman NR
Biochem Biophys Res Commun; 2011 Sep; 413(2):159-63. PubMed ID: 21871872
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
[TBL] [Abstract][Full Text] [Related]
3. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
4. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
6. Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo.
Tovar-Y-Romo LB; Santa-Cruz LD; Zepeda A; Tapia R
Neurochem Int; 2009; 54(3-4):186-91. PubMed ID: 19100799
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
Sen I; Nalini A; Joshi NB; Joshi PG
J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
[TBL] [Abstract][Full Text] [Related]
8. Persistent cleavage and nuclear translocation of apoptosis-inducing factor in motor neurons in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Yamamoto T; Kobayashi M
Acta Neuropathol; 2009 Dec; 118(6):755-62. PubMed ID: 19669652
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
Calingasan NY; Chen J; Kiaei M; Beal MF
Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
[TBL] [Abstract][Full Text] [Related]
10. Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons.
Jahn K; Grosskreutz J; Haastert K; Ziegler E; Schlesinger F; Grothe C; Dengler R; Bufler J
Neuroscience; 2006 Nov; 142(4):1019-29. PubMed ID: 16949760
[TBL] [Abstract][Full Text] [Related]
11. Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.
Zhao P; Ignacio S; Beattie EC; Abood ME
Eur J Neurosci; 2008 Feb; 27(3):572-9. PubMed ID: 18279310
[TBL] [Abstract][Full Text] [Related]
12. Exposure to cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients alters Nav1.6 and Kv1.6 channel expression in rat spinal motor neurons.
Gunasekaran R; Narayani RS; Vijayalakshmi K; Alladi PA; Shobha K; Nalini A; Sathyaprabha TN; Raju TR
Brain Res; 2009 Feb; 1255():170-9. PubMed ID: 19109933
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of parvalbumin on excitotoxic motor neuron death.
Van Den Bosch L; Schwaller B; Vleminckx V; Meijers B; Stork S; Ruehlicke T; Van Houtte E; Klaassen H; Celio MR; Missiaen L; Robberecht W; Berchtold MW
Exp Neurol; 2002 Apr; 174(2):150-61. PubMed ID: 11922657
[TBL] [Abstract][Full Text] [Related]
15. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis.
Cutler RG; Pedersen WA; Camandola S; Rothstein JD; Mattson MP
Ann Neurol; 2002 Oct; 52(4):448-57. PubMed ID: 12325074
[TBL] [Abstract][Full Text] [Related]
16. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
17. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
18. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
Kruman II; Pedersen WA; Springer JE; Mattson MP
Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
[TBL] [Abstract][Full Text] [Related]
19. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
20. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
